Price transparency
We focus on the difference between a quoted figure and the full set of practical costs a person may need to consider.
Palmaris / About
About
Palmaris is an independent resource on comparing ibogaine program pricing, inclusions, safety practices, and practical out-of-pocket costs. It helps people ask clearer questions about screening, monitoring, travel, and aftercare.
Purpose
We exist to make difficult comparisons more legible. Our work is organized for people and families who need a calmer starting point before they review the broader comparison framework or consider the practical questions outlined through our comparison services.
01 / Our editorial approach
Clear sourcing, careful boundaries.
Palmaris separates stated program details from interpretation. We use publicly available materials, registries, literature, official sources, and direct provider information where available, then label uncertainty rather than filling gaps with assumptions. That approach aligns with the ICMJE recommendations on transparent and responsible communication of evidence.
Information is reviewed for consistency, date context, and whether a claim can be traced to a source. Where information concerns health or safety, we distinguish description from advice and recognize that evidence can be incomplete, variable, or contested.
- 01Independence before promotion.
- 02Plain language without false certainty.
- 03Safety context alongside price context.
- 04Respectful clarity for people and families.
02 / What we cover
A practical map of the questions people ask.
Palmaris organizes information around what is included, what may remain out of pocket, how safety practices are described, and which questions are worth putting directly to a program. For terminology that appears inconsistently across materials, we note the names used for ibogaine rather than treating different wording as equivalent without context.
We also maintain pathways to compare descriptions of treatment costs in Mexico, Canadian ibogaine context, and market availability language. These are reference points, not endorsements, rankings, or guarantees.
Program inclusions
We make space for questions about what a stated program includes and what may require separate planning.
Safety context
We encourage clear questions about stated screening, monitoring, escalation, and aftercare practices without presenting advice.
03 / Who this is for
For decisions that deserve more than a headline number.
This resource is for people and families comparing options and trying to understand what questions belong in an informed conversation. It is also for readers who want a consistent way to inspect claims about an ibogaine treatment facility in Mexico before treating any individual statement as settled.
We encourage readers to consult appropriately qualified professionals for individual circumstances. The U.S. Food and Drug Administration’s information about ibogaine is one example of an official source that can help frame questions around regulatory and safety context.
“The goal is not to decide for anyone. It is to make the next question clearer.”
Because public descriptions can change, we present material as a starting point for verification. Readers may also encounter different framing in community discussion about ibogaine, which is why source, date, and scope always matter.
For a second pass on practical market language, our material also points to Mexico cost comparisons and Canada-focused reference material as separate, contextual sources.
04 / Independent by design
Information, not instruction.
Palmaris is independent of clinics and treatment centers. We do not provide medical or legal advice, and we do not substitute for professional assessment. This separation is intentional: it keeps the resource focused on clear questions, stated information, and the limits of what can be known from public materials.
Our reference work includes cross-checking language around available ibogaine market information, reviewing how a facility description is presented, and noting when alternative ibogaine terminology could obscure a comparison. The result is a framework for thought, not a recommendation to act.
Contact Palmaris